Filing Details
- Accession Number:
- 0001209191-22-062741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-27 18:41:33
- Reporting Period:
- 2022-12-22
- Accepted Time:
- 2022-12-27 18:41:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1253689 | Glycomimetics Inc | GLYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1945417 | Edwin Rock | C/O Glycomimetics, Inc 9708 Medical Center Drive Rockville MD 20850 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-22 | 110,000 | $2.25 | 310,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The Reporting Person purchased the securities on the open market at purchase prices ranging from $2.20 to $2.25 per share, with a weighted average purchase price of $2.25 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
